护理学报 ›› 2022, Vol. 29 ›› Issue (16): 37-42.doi: 10.16460/j.issn1008-9969.2022.16.037
欧阳蝶, 杨洁, 于相宇, 袁晓玲
OUYANG Die, YANG Jie, YU Xiang-yu, YUAN Xiao-ling
摘要: 目的 系统评价内分泌治疗对乳腺癌患者主客观认知功能的影响。方法 计算机检索The Cochrane Library、Medline、Embase、CINAHL、PubMed、Web of Science、中国生物医学文献数据库、万方、维普和中国知网期刊数据库建库至2021年10月31日的文献,根据纳入和排除标进行文献筛选、资料提取和质量评价,最后对纳入的文献进行总结分析。结果 共纳入11篇文献,结果显示,内分泌治疗对乳腺癌患者主客观认知功能影响的评定宜采用联合测试,客观认知表现以记忆力受损最为广泛,主客观认知功能影响的相关性较弱。结论 内分泌治疗对乳腺癌患者认知功能的影响结果尚待进一步统一,提示需关注乳腺癌患者远期认知功能损伤,开展更多高质量研究,进一步验证分析。
中图分类号:
[1] World Health Organization. Latest Global Cancer Data[EB/OL]. (2020-12-15). https://www.iarc.who.int/. [2] Vannorsdall TD.Cognitive Changes Related to Cancer Therapy[J]. Med Clin North Am, 2017,101(6):1115-1134. DOI:10.1016/j.mcna.2017.06.006. [3] Wu LM, Amidi A.Cognitive Impairment Following Hormone Therapy: Current Opinion of Research in Breast and Prostate Cancer Patients[J]. Curr Opin Support Palliat Care, 2017,11(1):38-45. DOI:10.1097/SPC.0000000000000251. [4] 张扬,罗太珍,林燕珊,等. 妇科癌症患者癌症相关性认知功能损害的神经心理学研究[J]. 护理学报,2019,26(15):70-75. DOI:10.16460/j.issn1008-9969.2019.15.070. [5] Dijkshoorn ABC, van Stralen HE, Sloots M, et al. Prevalence of Cognitive Impairment and Change in Patients with Breast Cancer: A Systematic Review of Longitudinal Studies[J]. Psychooncology,2021,30(5):635-648.DOI:10.1002/pon.5623. [6] Yamamoto S, Masutani E, Arao H.Self-reported Cognitive Decline in Japanese Patients with Breast Cancer Treated with Endocrine Therapy[J]. Breast Cancer, 2020,27(4):670-682. DOI:10.1007/s12282-020-01062-7. [7] Underwood EA, Rochon PA, Moineddin R, et al.Cognitive Sequelae of Endocrine Therapy in Women Treated for Breast Cancer: A Meta-analysis[J]. Breast Cancer Res Treat, 2018,168(2):299-310. DOI:10.1007/s10549-017-4627-4. [8] Lo CK, Mertz D, Loeb M.Newcastle-Ottawa Scale: Comparing Reviewers' to Authors' Assessments[J]. BMC Med Res Methodol, 2014,14:45. DOI:10.1186/1471-2288-14-45. [9] 周英凤,顾莺,胡雁,等. JBI循证卫生保健中心对关于不同类型研究的质量评价工具——患病率及分析性横断面研究的质量评价[J]. 护士进修杂志, 2018,33(3):219-221. DOI:10.16821/j.cnki.hsjx.2018.03.007. [10] Underwood EA, Jerzak KJ, Lebovic G, et al.Cognitive Effects of Adjuvant Endocrine Therapy in Older Women Treated for Early-stage Breast Cancer: A 1-year Longitudinal Study[J]. Support Care Cancer, 2019,27(8):3035-3043. DOI:10.1007/s00520-018-4603-5. [11] Biro E, Kahan Z, Kalman J, et al.Cognitive Functioning and Psychological Well-being in Breast Cancer Patients on Endocrine Therapy[J]. In Vivo, 2019,33(4):1381-1392. DOI:10.21873/invivo.11615. [12] Chen X, He X, Tao L, et al.The Working Memory and Dorsolateral Prefrontal-hippocampal Functional Connectivity Changes in Long-term Survival Breast Cancer Patients Treated with Tamoxifen[J]. Int J Neuropsychopharmacol, 2017,20(5):374-382. DOI:10.1093/ijnp/pyx008. [13] Chen X, Li J, Zhang J, et al.Impairment of The Executive Attention Network in Premenopausal Women with Hormone Receptor-positive Breast Cancer Treated with Tamoxifen[J]. Psychoneuroendocrinology,2017,75:116-123. DOI:10.1016/j.psyneuen.2016.10.020. [14] Berndt U, Leplow B, Schoenfeld R, et al.Memory and Spatial Cognition in Breast Cancer Patients Undergoing Adjuvant Endocrine Therapy[J]. Breast Care (Basel), 2016,11(4):240-246. DOI:10.1159/000446901. [15] Boele FW, Schilder CM, de Roode ML, et al. Cognitive Functioning During Long-term Tamoxifen Treatment in Postmenopausal Women with Breast Cancer[J]. Menopause, 2015,22(1):17-25. DOI:10.1097/GME.0000000000000271. [16] Chen X, Li J, Chen J, et al.Decision-making Impairments in Breast Cancer Patients Treated with Tamoxifen[J]. Horm Behav, 2014,66(2):449-456. DOI:10.1016/j.yhbeh.2014.07.005. [17] Lejbak L, Vrbancic M, Crossley M.Endocrine Therapy Is Associated with Low Performance on Some Estrogen-Sensitive Cognitive Tasks in Postmenopausal Women with Breast Cancer[J]. J Clin Exp Neuropsychol, 2010,32(8):836-846. DOI:10.1080/13803391003596389. [18] Schilder CM, Seynaeve C, Beex LV, et al.Effects of Tamoxifen and Exemestane on Cognitive Functioning of Postmenopausal Patients with Breast Cancer: Results From the Neuropsychological Side Study of the Tamoxifen and Exemestane Adjuvant Multinational Trial[J]. J Clin Oncol, 2010,28(8):1294-1300. DOI:10.1200/JCO.2008.21.3553. [19] Collins B, Mackenzie J, Stewart A, et al.Cognitive Effects of Hormonal Therapy in Early Stage Breast Cancer Patients: A Prospective Study[J]. Psychooncology, 2009,18(8):811-821. DOI:10.1002/pon.1453. [20] Shilling V, Jenkins V, Fallowfield L, et al.The Effects of Hormone Therapy on Cognition in Breast Cancer[J].J Steroid Biochem Mol Biol, 2003,86(3-5):405-412. DOI:10.1016/j.jsbmb.2003.07.001. [21] Bray VJ, Dhillon HM, Vardy JL.Systematic Review of Self-reported Cognitive Function in Cancer Patients Following Chemotherapy Treatment[J]. J Cancer Surviv, 2018,12(4):537-559. DOI:10.1007/s11764-018-0692-x. [22] Wechsler D.Wechsler Adult Intelligence Scale-third Edition[M]. San Antonio: The Psychological Corporation, 1997. [23] Meulen EF, Schmand B, van Campen JP, et al. The Seven Minute Screen: A Neurocognitive Screening Test Highly Sensitive to Various Types of Dementia[J]. J Neurol Neurosurg Psychiatry, 2004,75(5):700-705. DOI:10.1136/jnnp.2003.021055. [24] Rasmusson DX, Zonderman AB, Kawas C,et al.Effects of Age and Dementia on the Trail Making Test[J]. Clin neuropsychol,1998,12(2):169-178. DOI:10.1076/clin.12.2.169.2005. [25] Bender CM, Merriman JD, Gentry AL, et al.Patterns of Change in Cognitive Function with Anastrozole Therapy[J]. Cancer, 2015,121(15):2627-2636.DOI:10.1002/cncr.29393.[26] Rosen WG, Mohs RC, Davis KL. A New Rating Scale for Alzheimer's Disease[J]. Am J Psychiatry,1984, 141(11):1356-1364. DOI10.1176/ajp.141.11.1356. [27] Aaronson NK, Ahmedzai S, Bergman B, et al.The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-life Instrument for Use in International Clinical Trials in Oncology[J]. J Natl Cancer Inst, 1993,85(5):365-376. DOI:10.1093/jnci/85.5.365. [28] Winterling D, Crook T, Salama M, et al.A Self-rating Scale for Assessing Memory Loss[M].London: John Libbey Eurotext, 1986:482-486. [29] Broadbent DE, Cooper PF, FitzGerald P, et al. The Cognitive Failures Questionnaire (CFQ) and Its Correlates[J]. Br J Clin Psychol, 1982,21(1):1-16.DOI:10.1111/j.2044-8260.1982.tb01421.x. [30] Apple AC, Schroeder MP, Ryals AJ, et al.Hippocampal Functional Connectivity is Related to Self-reported Cognitive Concerns in Breast Cancer Patients Undergoing Adjuvant Therapy[J]. Neuroimage Clin, 2018,20:110-118. DOI:10.1016/j.nicl.2018.07.010. [31] Hutchinson AD, Hosking JR, Kichenadasse G, et al.Objective and Subjective Cognitive Impairment Following Chemotherapy for Cancer: A Systematic Review[J]. Cancer Treat Rev, 2012,38(7):926-934. DOI:10.1016/j.ctrv.2012.05.002. |
[1] | 邹自玉, 唐红梅, 吴丽, 陈荣凤, 梅花. 乳腺癌相关健康教育材料可读性评估的范围综述[J]. 护理学报, 2022, 29(9): 42-46. |
[2] | 燕文娟, 李壮苗, 余梦婷, 李施恩, 池艳红. 脑卒中患者病耻感影响因素的系统评价[J]. 护理学报, 2022, 29(8): 46-52. |
[3] | 朱飞, 路潜, 齐娟, 边颖, 庞立莎, 刘春蕾. 育龄期乳腺癌患者生育意愿的质性研究[J]. 护理学报, 2022, 29(7): 23-26. |
[4] | 廖敏, 李金花, 陈婕君, 程静, 李星凤. 乳腺癌患者基于互联网平台康复预警模型干预的效果观察[J]. 护理学报, 2022, 29(6): 73-78. |
[5] | 张营, 孟英涛, 尚美美, 杨德艳, 朱玉方, 王倩. 癌症相关认知功能障碍评估和管理的证据总结[J]. 护理学报, 2022, 29(3): 52-56. |
[6] | 吴丽, 陈荣凤, 邹自玉, 唐红梅. 问题提示列表在乳腺癌患者中临床应用效果的系统评价[J]. 护理学报, 2022, 29(2): 45-50. |
[7] | 石海宁, 陈玲, 周丽静, 王黎. 乳腺癌术后患者快速康复护理敏感质量指标体系的构建[J]. 护理学报, 2022, 29(15): 14-18. |
[8] | 何春燕, 郭丝锦, 林亚玮, 杜艳玲, 高丽, 曹宝花. 女性乳腺癌患者社会疏离特征及预测指标的研究[J]. 护理学报, 2022, 29(13): 6-11. |
[9] | 张爱萍, 段素伟. 社会疏离在康复期乳腺癌患者癌症复发恐惧与睡眠质量间的中介效应[J]. 护理学报, 2022, 29(13): 66-70. |
[10] | 郭盛丽, 袁薇, 朱婷, 林威娜, 陈晓容, 夏美燕. 患者结肠镜检查前肠道准备失败风险预测模型的系统评价[J]. 护理学报, 2022, 29(1): 35-40. |
[11] | 周田田, 王清, 黄萍, 陈雁. 安静时间对住院患者影响的系统评价[J]. 护理学报, 2021, 28(9): 29-34. |
[12] | 程爽, 熊振芳, 蔡艺, 陈涵彬, 惠靖瑞. 父母接受孤独症儿童诊断经历质性研究的系统评价[J]. 护理学报, 2021, 28(9): 35-42. |
[13] | 刘清玄, 张振香, 郭云飞, 张乐芸, 林蓓蕾, 梅永霞. 国内外脑卒中患者创伤后成长水平及其相关因素的系统评价[J]. 护理学报, 2021, 28(8): 1-7. |
[14] | 严露培, 姚丽丽, 赵庆华, 肖明朝, 李跃荣. 基于柯氏模型对TeamSTEPPS应用于医疗人员培训后效果维持的系统评价[J]. 护理学报, 2021, 28(8): 17-22. |
[15] | 李换则, 陈鸿芳, 黄丽群, 安芳芳, 徐鹏, 庄苗青, 张露语, 王嘉懿. 急诊科护士临终照护体验质性研究的Meta整合[J]. 护理学报, 2021, 28(7): 43-48. |
|